Survival According to Therapy Regimen for siNET: Data from 145 Patients from a German Tertiary Referral Centre, Preliminary Results
#2758
Introduction: Scarce data exists for therapy regimens other than SSRA and PRRT for siNET.
Aim(s): We analyzed real world data for differences in survival according to therapy.
Materials and methods: Retrospective, single center analysis of 145 patients, diagnosed between 1993 and 2018. Group (gr) 0: no treatment (n=10), gr 1: TACE and/or PRRT (n=25), gr. 2: SSRA (n=32), gr. 3: SSRA/PRRT (n=7), gr. 4: chemotherapy (n=8), gr. 5: not metastasized (at diagnosis), surgery only (n=53), gr. 6=metastasized (at diagnosis), surgery only (n= 10).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Bambey C, Koch C, Filmann N, Husmann G, Bojunga J,
Keywords: siNET, survival, multimodal therapy,
To read the full abstract, please log into your ENETS Member account.